Double-center observational study of minimally invasive sacroiliac joint fusion for sacroiliac joint dysfunction

Autor: Sem M M, Hermans, Rob J H, Knoef, Valérie N E, Schuermans, Martijn G M, Schotanus, Jorm M, Nellensteijn, Henk, van Santbrink, Inez, Curfs, Wouter L W, van Hemert
Přispěvatelé: Neurochirurgie, MUMC+: MA AIOS Neurochirurgie (9), Orthopedie, RS: CAPHRI - R6 - Promoting Health & Personalised Care, RS: CAPHRI - R3 - Functioning, Participating and Rehabilitation, MUMC+: MA Med Staf Spec Neurochirurgie (9)
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Journal of Orthopaedic Surgery and Research, 17(1):570. BioMed Central
ISSN: 1749-799X
DOI: 10.1186/s13018-022-03466-x
Popis: Background For a substantial part of patients with chronic low back pain, the origin is located in the sacroiliac joint (SIJ). Minimally invasive sacroiliac joint fusion (MISJF) is increasingly being implemented as a treatment option in SIJ dysfunction. Despite remaining controversy, evidence continues to increase. This study evaluates the clinical results and safety of MISJF in a double-center consecutive case series in patients with SIJ dysfunction over a one-year observation period. Methods SIJ complaints were diagnosed after history taking, physical examination and least a 50% reduction of SIJ pain 30–60 min following image-guided injection. Primary outcome measures were patient reported outcome measurements (PROMs), consisting of Visual Analogue Scale (VAS) pain score and EuroQol 5-dimensions 3-levels (EQ-5D-3L). Patients’ perspectives on the effects of surgery were collected through questionnaires. Secondary outcome measures were implant positioning and (serious) adverse events ((S)AE’s). Results A total of 29 patients were included. In 44.8% of patients, SIJ dysfunction was of postpartum origin. The mean VAS-pain score improved from 7.83 (± 1.71) to 4.97 (± 2.63) postoperatively (p p p = 0.026). In 13.7% of patients, an (S)AE occurred. Conclusion MISJF appears to be an effective and safe procedure in this cohort. Statistically significant and clinically relevant improvements in pain and quality of life were observed one-year postoperatively. Future studies should focus on the long-term outcomes to further evaluate the safety and effectiveness of MISJF.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje